Cite
HARVARD Citation
Buckley, C. et al. (n.d.). [O1–12–01]: [18F]FLUTEMETAMOL AMYLOID SCANNING IN A PHASE III AMNESTIC MILD COGNITIVE IMPAIRMENT STUDY: ADDITIONAL INFLUENCE OF OTHER BIOMARKERS IN ESTIMATING RISK OF CONVERSION TO PROBABLE ALZHEIMERS DISEASE. Alzheimer's & dementia. p. P221. [Online].